Multiple myeloma patient study shows promise for natural killer cells
Tuesday, December 8, 2015 - 09:56
in Health & Medicine
A first-in-human Phase I study of multiple myeloma patients combined expanded cord blood-derived natural killer cells with transplantation of a patient's own stem cells and high-dose chemotherapy with little or none of the side effects seen with current treatments.